GOOGL Reports July 22. The Stock Is Down About 10% From Its Post–Q1 Peak—and the Antitrust Risk Still Isn’t Cleanly Priced.
A ~$460B cloud backlog is real. So is a remedies decision that could reshape Google’s search and ad economics.
July 4, 2026
Big Pharma Has $1.3 Trillion to Spend. The Clock Is Running.
A patent cliff with a known deadline is forcing the largest acquisition wave in biopharma history.